Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Head & Neck 5Plasma cell 3Lymphoid 3Dermatologic 3Other hematologic neoplasm 2Genitourinary 2Gastrointestinal 2Gynecologic 1Classical hematology 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Fanconi Anemia 1

Interventions

Cyclophosphamide 11fludarabine phosphate 9Whole-Body Irradiation 8Mycophenolic Acid 7Busulfan 6fludarabine 5Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Rituximab 4Biopsy 4Azacitidine 4venetoclax 3apixaban 3Cyclosporine 3thymoglobulin 2decitabine and cedazuridine drug combination 2Vorinostat 2Vancomycin 2Tretinoin 2Specimen Handling 2Sirolimus 2Methotrexate 2Lenalidomide 2Injections 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Decitabine 2Cytarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Afatinib × Classical hematology × 90 days × Clear all
NCT06648096 2026-05-27

AFAN

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1/2 Recruiting
25 enrolled
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡